[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-346371-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-346371-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","multimodal-profiling-of-pancreatic-cancer-reveals-a-timp-1-dominated-secretory-profile-determining-pro-tumor-immunoinstruction-in-human-cancers","Multimodal profiling of pancreatic cancer reveals a TIMP-1-dominated secretory profile determining pro-tumor immunoinstruction in human cancers","","By integrating multiomic profiling across human cancers, Fr¨adrich and colleagues identify a secretory inflammatory signature (CISS) that links malignant evolution to immunosuppression and poor patient survival. In pancreatic ductal adenocarcinoma, the signature emerges in pre-malignant epithelium, strengthens through transformation to basal-like disease, and tracks suppressed natural killer (NK) cell activity. TIMP-1 quantitatively dominates CISS, driving pancreatic cancer-cell-mediated NK suppression. The TIMP-1/CISS axis is targetable in pre-clinical models using clinically approved kinase inhibitor combinations.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/multimodal-profiling-of-pancreatic-cancer-reveals-a-timp-1-dominated-secretory-profile-determining-pro-tumor-immunoinstruction-in-human-cancers/346371/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/multimodal-profiling-of-pancreatic-cancer-reveals-a-timp-1-dominated-secretory-profile-determining-pro-tumor-immunoinstruction-in-human-cancers/346371.png","ImageObject",300,407,{"name":42,"@type":43},"Himbo","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-14","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main discovery of this study in human cancers?","Question",{"text":63,"@type":64},"The study identifies a cancer-immunoinstructive secretory signature (CISS) that links malignant evolution to immunosuppression and poor patient survival.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does CISS behave specifically in pancreatic cancer?",{"text":68,"@type":64},"In pancreatic cancer, CISS arises in pre-malignant epithelium, intensifies along transformation toward malignant basal-like cancer, and correlates with suppressed NK cell activity.",{"name":70,"@type":61,"acceptedAnswer":71},"Why is TIMP-1 important, and can the pathway be targeted?",{"text":72,"@type":64},"TIMP-1 quantitatively dominates CISS (especially in TIMP-1hi/CISShi basal-like tumors) and is causal for pancreatic cancer-cell-mediated NK suppression; TIMP-1/CISS is targetable pre-clinically using clinically approved kinase inhibitors such as trametinib and nintedanib.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},346371,1790193282,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":112,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},687197100911,"https://ap-avatar.wpscdn.com/avatar/a000239b6f1da00475?x-image-process=image/resize,m_fixed,w_180,h_180&k=1785132997149421697","Article  \nMultimodal profiling of pancreatic cancer reveals a TIMP-1-dominated secretory profile determining pro-tumor immunoinstruction in human cancers  \nAuthors  \nJulian Fr¨adrich, Carmen Mota Reyes, Michel Hendel,   , Dieter Saur, Ihsan Ekin Demir, Achim Kru¨ger  \nCorrespondence  \n[achim.krueger@tum.de](achim.krueger@tum.de)  \nIn brief  \nBy multiomic profiling across human cancers, Fr¨adrich et al. discover a secretory profile linking malignant evolution to immunosuppression and poor patient survival. In pancreatic cancer, this profile is shaped by TIMP-1-dependent NK cell suppression and proves targetable through clinically approved kinase inhibitors, highlighting exploitable prognostic and therapeutic potential.  \n• In PDAC, CISS arises in pre-malignancy and culminates in TIMP-1hi basal-like cancer  \n• PDAC-cell-mediated NK cell suppression is TIMP-1-dependent  \n• TIMP1/CISS identify high-risk patients and prove targetable in pre-clinical PDAC  \nFr¨adrich et al., 2026, Cell Reports Medicine 7, 102546  \nJanuary 20, 2026 © 2025 The Author(s) . Published by Elsevier Inc.  \n[https://doi.org/10.1016/j.xcrm.2025.102546](https://doi.org/10.1016/j.xcrm.2025.102546)  \nll  \nll  \nOPEN ACCESS  \nArticle  \nMultimodal profiling of pancreatic cancer reveals a TIMP-1-dominated secretory profile determining pro-tumor immunoinstruction in human cancers  \nJulian Fr¨adrich,1 Carmen Mota Reyes,2,3,4,5 Michel Hendel,1 Vanessa Brunner,1 Batu Toledo,1 Damjan Manevski,1 Alexander Sommer,1 Daniel H¨außler,1 Dominik Beck,1 Daniele Lucarelli,6,7 Jaime Martnez de Villareal,8,9 Lennard Halle,7 Raphael Kfuri-Rubens,7 Kaan C¸ifcibas‚ ı,2 Anna Hirschberger,10 Rupert ¨Ollinger,11 Percy A. Knolle,10 Katja Steiger,12 Roland Rad,11 Fabian J. Theis,7,13,14 Francisco X. Real,8,9,15 Stefanie B¨arthel,6,16,17 Jan P. B¨ottcher,10,18,19  \nDieter Saur,3,6,16 Ihsan Ekin Demir,2,3,4,20 and Achim Kru¨ger1,21,*  \n1TUM School of Medicine and Health, Institute of Experimental Oncology and Therapy Research, Technical University of Munich, Munich, Germany  \n2TUM School of Medicine and Health, Department of Surgery, Technical University of Munich, Munich, Germany  \n3German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany  \n4Neural Influences in Cancer (NIC), International Research Consortium, Munich, Germany  \n5Bayerisches Zentrum fu¨r Krebsforschung (BZKF), Munich, Germany  \n6TUM School of Medicine and Health, Center for Translational Cancer Research (TranslaTUM), Technical University of Munich, Munich, Germany  \n7Institute of Computational Biology, Computational Health Center, Helmholtz Munich, Neuherberg, Germany  \n8Epithelial Carcinogenesis Group, Spanish National Cancer Research Centre, Madrid, Spain  \n9Centro Nacional de Investigaciones Onc´ologicas (CNIO), 28029 Madrid, Spain  \n10TUM School of Medicine and Health, Institute of Molecular Immunology, Technical University of Munich, Munich, Germany  \n11TUM School of Medicine and Health, Institute of Molecular Oncology and Functional Genomics, Technical University of Munich, Munich, Germany  \n12TUM School of Medicine and Health, Department of Pathology, Technical University of Munich, Munich, Germany  \n13TUM School of Computation, Information and Technology, Department of Mathematics, Technical University of Munich, Garching, Germany  \n14TUM School of Life Sciences, Weihenstephan, Technical University of Munich, Freising, Germany  \n15Department of Medicine and Life Sciences, Universitat Pompeu Fabra, 08003 Barcelona, Spain  \n16Division of Translational Cancer Research, German Cancer Research Center and German Cancer Consortium, Heidelberg, Germany  \n17BioMed X Institute Heidelberg, Heidelberg, Germany  \n18Department of Experimental Immunology, Institute of Immunology, University of Tu¨bingen, Tu¨bingen, Germany  \n19M3 Research Center, University Hospital Tu¨bingen, University of Tu¨bingen, Tu¨bingen, Germany  \n20Else Kr¨oner Clinician Scientist Professor for Translational Pancreatic Surgery, Technical Unive","cbCaia7vjIWsw4GR","https://ap.wps.com/l/cbCaia7vjIWsw4GR","pdf",13322379,"English","# Summary\n## Key findings\n## Methods and evidence\n## Therapeutic implication","[{\"question\":\"What is the main discovery of this study in human cancers?\",\"answer\":\"The study identifies a cancer-immunoinstructive secretory signature (CISS) that links malignant evolution to immunosuppression and poor patient survival.\"},{\"question\":\"How does CISS behave specifically in pancreatic cancer?\",\"answer\":\"In pancreatic cancer, CISS arises in pre-malignant epithelium, intensifies along transformation toward malignant basal-like cancer, and correlates with suppressed NK cell activity.\"},{\"question\":\"Why is TIMP-1 important, and can the pathway be targeted?\",\"answer\":\"TIMP-1 quantitatively dominates CISS (especially in TIMP-1hi/CISShi basal-like tumors) and is causal for pancreatic cancer-cell-mediated NK suppression; TIMP-1/CISS is targetable pre-clinically using clinically approved kinase inhibitors such as trametinib and nintedanib.\"}]","Multimodal profiling of pancreatic cancer reveals a TIMP-1-dominated secretory profile determining pro-tumor immunoinstruction in human cancers | PDF",1790061133,76,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3faf922ee7dfa2b9c7cb571215207fe1.webp",983,1276,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/da8d82c2393090ae5650b5b00c17f529.webp",982,1275,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f41232b598b6ec928de80fc63e9c5390.webp",981,1273,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0bffbe546912613f81a4d78bdaafa04d.webp",980,1272]